Subcutaneous administration of alemtuzumab in simultaneous pancreas-kidney transplantation.

scientific article

Subcutaneous administration of alemtuzumab in simultaneous pancreas-kidney transplantation. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/01.TP.0000295718.55669.3A
P698PubMed publication ID18165765

P50authorChristopher J WatsonQ60057362
Menna R ClatworthyQ64821225
P2093author name stringAndrew J Butler
Rajesh Sivaprakasam
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectpancreasQ9618
P304page(s)1563-1567
P577publication date2007-12-01
P1433published inTransplantationQ15730500
P1476titleSubcutaneous administration of alemtuzumab in simultaneous pancreas-kidney transplantation
P478volume84

Reverse relations

cites work (P2860)
Q43970258Alemtuzumab induction in deceased donor kidney transplantation
Q44701983Alemtuzumab induction in simultaneous pancreas and kidney transplantation
Q42943652Alemtuzumab with rapid steroid taper in simultaneous kidney and pancreas transplantation: comparison to induction with antithymocyte globulin
Q38009874Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation.
Q38206175Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options
Q36163297Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) in Patients With Serous Ovarian Carcinoma and Their Clinical Significance.
Q38162892Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective
Q37738864Immunosuppression in simultaneous pancreas-kidney transplantation: progress to date
Q37755276Monoclonal antibody-induced cytokine-release syndrome
Q48603371Outcomes of simultaneous pancreas-kidney transplantation from brain-dead and controlled circulatory death donors.
Q39409394Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation.
Q35963432Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation
Q38769922Use of polyclonal/monoclonal antibody therapies in transplantation

Search more.